<DOC>
	<DOCNO>NCT02817308</DOCNO>
	<brief_summary>Ductal adenocarcinoma pancreas fifth lead cause cancer relate death European Union . Tumor marker CA19-9 carcinoembryonic antigen important component decision make follow-up patient diagnosed disease . These tumor marker find elevate serum also body fluid patient malignant lesion parotid gland urinary tract . The author describe preview small preliminary study positive strong linear correlation level CA19-9 urine saliva present serum patient ductal adenocarcinoma pancreas . The current study seek enlarge study population confirm previous result standardize measured level CA19-9 body fluid .</brief_summary>
	<brief_title>Correlation Serum CA19-9 Levels With Levels Saliva Urine Patients With Ductal Adenocarcinoma Pancreas</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Carcinoma , Pancreatic Ductal</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Patients : Proven diagnosis ductal adenocarcinoma pancreas elevate level CA199 possible elevated level CEA Controls : Previous diagnosis malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Antigen , CA-19-9</keyword>
	<keyword>Salivas</keyword>
	<keyword>body fluid</keyword>
</DOC>